Literature DB >> 10809259

Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.

G M Annich1, J P Meinhardt, K A Mowery, B A Ashton, S I Merz, R B Hirschl, M E Meyerhoff, R H Bartlett.   

Abstract

OBJECTIVE: To determine whether the use of nitric oxide (NO)-releasing polymers coated onto the inner surface of extracorporeal circuits can reduce platelet consumption and activation in the absence of systemic heparinization using a rabbit model of venovenous extracorporeal circulation.
DESIGN: Prospective, controlled trial.
SETTING: Research laboratory at an academic medical institution.
SUBJECTS: New Zealand White Rabbits.
INTERVENTIONS: Anesthetized, tracheotomized, and ventilated New Zealand White rabbits were injected with freshly prepared, 111In(oxine)3 labeled single donor platelets through the external jugular vein. After baseline measurements, these animals were placed on venovenous extracorporeal circulation through a 1-m control circuit or NO test circuit for 4 hrs at a blood flow rate of 109-118 mL/min via roller pump. Four groups were studied: systemically heparinized control circuits, systemically heparinized NO test circuits, nonheparinized control circuits, and nonheparinized NO test circuits. Platelet counts, fibrinogen levels, and plasma free indium levels were measured hourly. Circuits were rinsed and retained for gamma counting after the 4-hr run or when the circuit clotted. Four animals, one from each group, did not receive radiolabeled platelets so that the circuits could be preserved for scanning electron microscopic examination after the 4-hr study.
MEASUREMENTS AND MAIN RESULTS: Platelet consumption was significantly reduced in both the heparinized and nonheparinized NO test groups when compared with the controls (p < .0001 and p < .0004, respectively). Platelet adhesion to the extracorporeal circuits was significantly reduced in the nonheparinized test circuits when compared with the controls (p < .05). Scanning electron microscopic examination of the circuits revealed that in the absence of heparin and in the presence of a NO-releasing surface, platelets retained their spherical nonactivated shape.
CONCLUSIONS: The incorporation of NO into the surface of extracorporeal circuits reduces platelet consumption and eliminates the need for systemic heparinization in a rabbit model of extracorporeal circulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809259     DOI: 10.1097/00003246-200004000-00001

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  36 in total

Review 1.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

Review 2.  The artificial endothelium.

Authors:  Melissa M Reynolds; Gail M Annich
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

Review 3.  The evolution of patient selection criteria and indications for extracorporeal life support in pediatric cardiopulmonary failure: next time, let's not eat the bones.

Authors:  Joseph R Custer
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

4.  Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.

Authors:  Michele C Jen; María C Serrano; Robert van Lith; Guillermo A Ameer
Journal:  Adv Funct Mater       Date:  2012-01-25       Impact factor: 18.808

5.  The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation.

Authors:  Terry C Major; Elizabeth J Brisbois; Anna M Jones; Margaux E Zanetti; Gail M Annich; Robert H Bartlett; Hitesh Handa
Journal:  Biomaterials       Date:  2014-06-10       Impact factor: 12.479

6.  Reduction in Thrombosis and Bacterial Adhesion with 7 Day Implantation of S-Nitroso-N-acetylpenicillamine (SNAP)-Doped Elast-eon E2As Catheters in Sheep.

Authors:  Elizabeth J Brisbois; Ryan P Davis; Anna M Jones; Terry C Major; Robert H Bartlett; Mark E Meyerhoff; Hitesh Handa
Journal:  J Mater Chem B       Date:  2015-02-28       Impact factor: 6.331

Review 7.  Nitric Oxide Therapy for Diabetic Wound Healing.

Authors:  Maggie J Malone-Povolny; Sara E Maloney; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2019-01-15       Impact factor: 9.933

Review 8.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

9.  Electromodulated Release of Nitric Oxide Through Polymer Material from Reservoir of Inorganic Nitrite Salt.

Authors:  Lajos Höfler; Dipankar Koley; Jianfeng Wu; Chuanwu Xi; Mark E Meyerhoff
Journal:  RSC Adv       Date:  2012-07-12       Impact factor: 3.361

10.  Development of an artificial placenta V: 70 h veno-venous extracorporeal life support after ventilatory failure in premature lambs.

Authors:  Brian W Gray; Ahmed El-Sabbagh; Sara J Zakem; Kelly L Koch; Alvaro Rojas-Pena; Gabe E Owens; Martin L Bocks; Raja Rabah; Robert H Bartlett; George B Mychaliska
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.